MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

National Luxembourg Sleep Study: An enriched, at risk, prodromal Parkinson’s Disease cohort

D. Mcintyre, L. Pavelka, C. Pauly, G. van Cutsem, O. Tsurkalenko, T. Marques, C. Gomes, S. Jonsdottir, J. Welch, K. Gunter, G. Aguayo, A. Sharify, E. Rosalès-Jubal, M. Vaillant, V. Satagopam, S. Ghosh, C. Vega Moreno, K. Roomp, A. Pincherle, M. Gantenbein, N. Diederich, M. Hu, R. Krüger, L. Vilas Boas (Luxembourg, Luxembourg)

Meeting: 2023 International Congress

Abstract Number: 621

Keywords: Alpha-synuclein, Sleep disorders. See also Restless legs syndrome: Clinical features, Sleep disorders. See also Restless legs syndrome: Etiology and Pathogenesis

Category: Epidemiology

Objective: To identify a cognitively intact enriched cohort of people with isolated rapid eye movement (iREM) sleep behaviour disorder (iRBD) and hyposmia, at risk of phenoconversion to Parkinson’s disease (PD). This cohort will be followed longitudinally to gain insights into disease mechanisms and epidemiology.

Background: Hyposmia[i] and iRBD are biomarkers of prodromal α-synucleinopathies[ii] such as PD.

Method: Residents of Luxembourg aged 55-75 were invited to complete an online survey including the 1-item Mayo Sleep Questionnaire, 13-item RBD Screening Questionnaire (RBDSQ) and 16-item Short IQCODE. Individuals with RBDSQ≥7 underwent a structured telephone interview then, those qualifying, at-home olfactory tests (Short UPSIT) and a Parkinson’s Disease Screening Questionnaire. Finally, subjects with hyposmia but no signs of PD were invited for in-person cognitive screening and physical examination. Participants with clinically probable iRBD (pRBD) were referred for polysomnography (PSG) for RBD confirmation.

Results: 17,502 (13% of 134,098 invited) participated in the online survey; 1,987 had clinically pRBD. After telephone assessment, 666 qualified for home based olfactory testing. 592 (89%) completed; 204 had hyposmia (UPSIT≤8) and were invited for in-person visits (179 completed); 116 qualified for PSG. To date, 54 PSGs confirm 34 (62%) iRBD (28) or REM sleep without atonia (6); 8 obstructive sleep apnoea syndrome and 1 periodic limb movements.

Conclusion: This nationwide study is one of the most extensive pRBD prevalence surveys leading to an enriched cohort at-risk for PD. The systematic, stepwise screening process not only informs about population prevalence of pRBD, but also provides lessons for enrichment of a cohort of people at increased risk of PD.

References: [i] Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, Gornall A, Klein JC, Lo C, Dennis G, Bandmann O, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Hu MTM. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder. Sleep. 2017 Aug 1;40(8):zsx071. doi: 10.1093/sleep/zsx071. PMID: 28472425; PMCID: PMC5806544.
[ii] Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain. 2012 Jun;135(Pt 6):1860-70. doi: 10.1093/brain/aws093. Epub 2012 May 4. PMID: 22561644.

To cite this abstract in AMA style:

D. Mcintyre, L. Pavelka, C. Pauly, G. van Cutsem, O. Tsurkalenko, T. Marques, C. Gomes, S. Jonsdottir, J. Welch, K. Gunter, G. Aguayo, A. Sharify, E. Rosalès-Jubal, M. Vaillant, V. Satagopam, S. Ghosh, C. Vega Moreno, K. Roomp, A. Pincherle, M. Gantenbein, N. Diederich, M. Hu, R. Krüger, L. Vilas Boas. National Luxembourg Sleep Study: An enriched, at risk, prodromal Parkinson’s Disease cohort [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/national-luxembourg-sleep-study-an-enriched-at-risk-prodromal-parkinsons-disease-cohort/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/national-luxembourg-sleep-study-an-enriched-at-risk-prodromal-parkinsons-disease-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley